Results of four years multicenter study of the Sundimmun Neoral efficacy in children with nephrotic syndrome
Abstract
About the Authors
M. S. IgnatovaRussian Federation
E. A. Kharina
Russian Federation
O. Yu. Turpitko
Russian Federation
V. A. Obukhova
Russian Federation
N. A. Korovina
Russian Federation
N. A. Chruscheva
Russian Federation
G. A. Makovezkaja
Russian Federation
M. K. Soboleva
Russian Federation
A. B. Kanatbayeva
Russian Federation
References
1. Игнатова М.С., Харина Е.А., Курбанова Э.Г. и др. Эффективность Сандиммуна Неорала при нефротическом синдроме у детей России и Казахстана по данным многоцентрового контролируемого исследования. Педиатрия 2001; 6: 90-94.
2. Collaborative Study group of Sandimmune in Nephrotic Syndrome. Safety and tolerability of cyclosporin A in idiopathic nephrotic syndrome. Clin Nephrol 1994; 35: S37-S42.
3. Iijima K., Hamahira K., Tanaka R. et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal changes nephrotic syndrome. Kidney Int 2002; 61: 1801-1805.
4. Kurbanova E., Ignatova M., Kharina E. et al. Behaviour of NK-cells in nephrotic syndrome (NS) as a predictive factor of cyclosporin A (CsA) efficacy. The 11th Congress of the IPNA. London, UK: Pediatric Nephrology 1998 Sept 12-16; Abstracts; 109: 126.
5. Niaudet P. and French Society of Pediatric Nephrology. Treatment of childhood steroid resistant idiopathic nephrosis with the combination of cyclosporine and prednisolone J of Pediarics 1994; 125: 981-985.
6. Niaudet P., Habib R. Cyclosporine in the treatment of idiopathic nephrotic syndrome. J Am Soc Nephrol 1994; 5: 1049-1056.
7. Seikaly M., Prashner H., Nolde-Hurlbert B. et al. Long-term clinical and pathological effects of cyclosporin in children with nephrosis. Pediatr nephrol 2000; 14: 214-217.
8. Tejani A., Butt K., Trachman H. et al. Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J Pediatr 1987; 111: 1056-1062.
9. Yang H., Ahn H., Kim W. et al. Cyclosporin withdrawal and mycophenolate mofetil treatment effect on the progression of chronic cyclosporin nephrotoxicity. Kidney Int 2002; 62: 20-30.
Review
For citations:
Ignatova M.S., Kharina E.A., Turpitko O.Yu., Obukhova V.A., Korovina N.A., Chruscheva N.A., Makovezkaja G.A., Soboleva M.K., Kanatbayeva A.B. Results of four years multicenter study of the Sundimmun Neoral efficacy in children with nephrotic syndrome. Nephrology and Dialysis. 2003;5(2):144-147. (In Russ.)